InvestorsHub Logo
Followers 4
Posts 1608
Boards Moderated 0
Alias Born 09/07/2006

Re: John266 post# 115

Tuesday, 12/26/2006 10:18:10 AM

Tuesday, December 26, 2006 10:18:10 AM

Post# of 413
why are you so ridicolous?

DOV has 1.77$ cash per share? That's not their money, that's the money the debenture holders gave them and not they might ask it back, noone knows. Management has been buying stock? They can't during the reorganization due to insider trading restrictions.

But the one thing you posted that I loved more was this:

"on 7 December 2006, DOVP.PK announced that Merck had given up on DOV Patents as a business decision after the poor clinical trial results on radiating leg pain reported this summer. Curiously, DOVP.PK stock went up. A week later we found out why. DOV Pharm announced better patent royalty agreements with Wyeth."

of course you have no idea on what you're talking about and don't even took your time so understand that "trial results on radiating leg pain" was associated with bicifadine results, and that the Merck partnerships was for dov 21,947 and dov 216,303, mostly targeting depression and anxiety disorders.

Kid...

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.